BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2305464)

  • 21. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A
    Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OKT3 for primary therapy of the first rejection episode in kidney transplants.
    Tesi RJ; Elkhammas EA; Henry ML; Ferguson RM
    Transplantation; 1993 May; 55(5):1023-9. PubMed ID: 8497875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of 2-drug and 3-drug immunosuppression for cadaveric renal transplantation.
    Martin DC; Tertzakian G; Ruzics E
    J Urol; 1990 May; 143(5):900-1. PubMed ID: 2329602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kidney transplantation, the Halifax experience.
    Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B; West K; Sketris I
    Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective randomized comparison of quadruple versus triple therapy for first cadaver transplants with immediate function.
    Slakey DP; Johnson CP; Callaluce RD; Browne BJ; Zhu YR; Roza AM; Adams MB
    Transplantation; 1993 Oct; 56(4):827-31. PubMed ID: 8212201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term and long-term function of cadaveric kidneys from pediatric donors in recipients treated with cyclosporine.
    Smith AY; Van Buren CT; Lewis RM; Kerman RH; Kahan BD
    Transplantation; 1988 Feb; 45(2):360-7. PubMed ID: 3278429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outlook for renal transplant recipients with one-year function. "Doctor, what are my chances"?
    Fischel RJ; Payne WD; Gillingham KJ; Dunn DL; Sutherland DE; Matas AJ; Najarian JS
    Transplantation; 1991 Jan; 51(1):118-22. PubMed ID: 1987680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience.
    Tanabe K; Takahashi K; Sonda K; Tokumoto T; Ishikawa N; Kawai T; Fuchinoue S; Oshima T; Yagisawa T; Nakazawa H; Goya N; Koga S; Kawaguchi H; Ito K; Toma H; Agishi T; Ota K
    Transplantation; 1998 Jan; 65(2):224-8. PubMed ID: 9458019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic rejection in primary renal allograft recipients under cyclosporine-prednisone immunosuppressive therapy.
    Knight RJ; Kerman RH; Welsh M; Golden D; Schoenberg L; Van Buren CT; Lewis RM; Kahan BD
    Transplantation; 1991 Feb; 51(2):355-9. PubMed ID: 1994527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal transplantation at the University of Pennsylvania Medical Center: an update of results in the cyclosporine era.
    Brayman KL; Egidi FM; Naji A; Friedman AL; Perloff L; Grossman R; Zmijewski CM; Cameron E; Kobrin S; Feldman H
    Clin Transpl; 1992; ():215-25. PubMed ID: 1306700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients.
    Schulak JA; Mayes JT; Moritz CE; Hricik DE
    Transplantation; 1990 Feb; 49(2):327-32. PubMed ID: 2407003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Causes of late renal allograft failure in the ciclosporin era.
    Hong JH; Sumrani N; Delaney V; Davis R; Dibenedetto A; Butt KM
    Nephron; 1992; 62(3):272-9. PubMed ID: 1436337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effective induction immunosuppression for cadaver renal transplantation at the St. Francis Regional Medical Center.
    Shield CF
    Clin Transpl; 1990; ():265-74. PubMed ID: 2129408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful transplantation of 100 untransfused cyclosporine-treated primary recipients of cadaveric renal allografts.
    Kerman RH; Van Buren CT; Lewis RM; Kahan BD
    Transplantation; 1988 Jan; 45(1):37-40. PubMed ID: 3276059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, prospective trial of cyclosporine monotherapy versus azathioprine-prednisone from three months after renal transplantation.
    Hilbrands LB; Hoitsma AJ; Koene KA
    Transplantation; 1996 Apr; 61(7):1038-46. PubMed ID: 8623182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric renal transplants--results with sequential immunosuppression.
    Almond PS; Matas AJ; Gillingham K; Moss A; Mauer M; Chavers B; Nevins T; Kashtan C; Dunn D; Payne W
    Transplantation; 1992 Jan; 53(1):46-51. PubMed ID: 1733084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal transplantation at the University of Minnesota during the 1980s.
    Fryd DS; Migliori R; Simmons RL; Chavers B; Dunn D; Payne W; Canafax DM; Sutherland DE; So SS; Mauer SM
    Clin Transpl; 1987; ():167-81. PubMed ID: 3154396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.